Matthew Rabinowitz sold $642K of Natera (NTRA)

Executed Aug 7, disclosed Aug 8, the same day.

Value, as filed

$642K

2,000 sh × $320.90

Executed

Aug 7

the trade date, as filed

Disclosed

Aug 8

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Matthew Rabinowitz EXECUTIVE CHAIRMAN profile →

Matthew Rabinowitz (EXECUTIVE CHAIRMAN) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Natera, Inc. (NTRA). The largest single filing was $38.1M of NTRA (199,246 sh across 19 lots, as filed), executed Mar 12.

The name

NTRA

Natera, Inc. NTRA · Healthcare · 219 filings in 24 months ticker →

Healthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Matthew Rabinowitz in NTRA

NTRASALE Natera, Inc. $34.8M
102,000 sh across 29 lots
Exec Sep 14
Filed Sep 16 · 9:35 PM ET NTRASALE Natera, Inc. $16.4M
50,000 sh across 6 lots
Exec Sep 11
Filed Sep 11 · 9:35 PM ET NTRASALE Natera, Inc. $196K
731 sh × $267.99
Exec Aug 3
Filed Aug 5 · 9:35 PM ET NTRASALE Natera, Inc. $448K
1,718 sh × $260.49
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $280K
1,000 sh × $280.00
Exec Jul 6
Filed Jul 8 · 9:05 PM ET NTRASALE Natera, Inc. $21.4M
99,600 sh across 20 lots
Exec Jun 12
Filed Jun 16 · 5:30 PM ET NTRASALE Natera, Inc. $1.6M
7,708 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET NTRASALE Natera, Inc. $38.1M
199,246 sh across 19 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET